KRRO
KRRO
NASDAQ · Biotechnology

Korro Bio Inc

$10.13
-0.27 (-2.60%)
As of Mar 30, 3:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
9.80M
Net Income
-179,837,502
Gross Margin
44.7%
Profit Margin
-1,834.5%
Rev Growth
-23.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 44.7% 44.7% 36.3% 36.3%
Operating Margin -1,906.4% -1,715.7% -18.2% -15.4%
Profit Margin -1,834.5% -1,742.8% -21.6% -18.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.80M 12.75M 16.40M 15.17M
Gross Profit 4.38M 5.70M 5.95M 5.50M
Operating Income -186,875,541 -218,766,892 -2,982,822 -2,336,962
Net Income -179,837,502 -210,527,772 -3,544,265 -2,816,245
Gross Margin 44.7% 44.7% 36.3% 36.3%
Operating Margin -1,906.4% -1,715.7% -18.2% -15.4%
Profit Margin -1,834.5% -1,742.8% -21.6% -18.6%
Rev Growth -23.1% -23.1% +19.8% +8.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 18.25M 14.30M
Total Equity 49.68M 50.11M
D/E Ratio 0.37 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -172,295,641 -212,904,343 -3,398,004 -2,964,187
Free Cash Flow -3,167,900 -2,994,560